Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 72162-2501

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 72162-2501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622501)

Label for Sevelamer Hydrochloride tablets, 800 mg strength, presented as film-coated oral tablets. The package contains 180 tablets. The label indicates the product is relabeled by Bryant Ranch Prepack, Inc. in Burbank, CA, and manufactured by Macleods Pharmaceuticals Ltd. Storage instructions and QR codes for prescribing information are included, alongside the NDC 72162-2501-2 and barcodes.*

FDA Label Image

Figure-2 (Sevelamer Figure 2)

A cumulative percentage graph showing the percentage of patients with at least a given reduction in serum phosphorus (mg/dL) on the x-axis against the percentage of patients on the y-axis. Two lines are plotted, one for Sevelamer Hydrochloride and one for an active control. The graph illustrates patient responses to treatment in terms of change from baseline serum phosphorus levels.*

FDA Label Image

Figure-3 (Sevelamer Figure 3)

A line graph depicting phosphorus change from baseline over a 52-week study period. The graph compares Sevelamer Hydrochloride with an active-control treatment, showing phosphorus levels on the vertical axis and study weeks on the horizontal axis. Two lines represent the treatment groups' changes in phosphorus over time.*

FDA Label Image

Figure-1 (Sevelamer Structure)

Chemical structure diagram of Sevelamer Hydrochloride, showing the polymeric molecular framework with multiple amine (NH2) and hydrochloride (HCl) groups attached, including side chains containing hydroxyl (OH) groups. The structure illustrates the complex repeating units of this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.